We are live on ! Find out more
SCM

Semanteon Capital Management Portfolio holdings

AUM $7.45M
1-Year Est. Return 55.81%
This Fund
S&P 500
This Quarter Est. Return
-6.24%
1 Year Est. Return
+55.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
-$2.27M
Cap. Flow
+$16.6M
Cap. Flow %
9.02%
Top 10 Hldgs %
8.33%
Holding
377
New
150
Increased
30
Reduced
55
Closed
142

Top Buys

Rank Stock Value
1
AI icon
C3.ai
AI
+$1.93M
2
ICFI icon
ICF International
ICFI
+$1.86M
3
FLNC icon
Fluence Energy
FLNC
+$1.78M
4
W icon
Wayfair
W
+$1.72M
5
ALGN icon
Align Technology
ALGN
+$1.72M

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$1.57M
2
REAL icon
The RealReal
REAL
+$1.56M
3
AMZN icon
Amazon
AMZN
+$1.52M
4
LEA icon
Lear
LEA
+$1.48M
5
RRR icon
Red Rock Resorts
RRR
+$1.48M

Sector Composition

Rank Sector Weight
1 Industrials 22.04%
2 Technology 16.85%
3 Consumer Discretionary 14.66%
4 Healthcare 11.94%
5 Materials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEI
376
Solaris Energy Infrastructure
SEI
$3.82B
-27,638
Closed -$795K
CFB
377
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
-24,376
Closed -$369K

Similar funds

Semanteon Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Semanteon Capital Management held 377 positions worth $184M, down 1.2% from $186M the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Semanteon Capital Management deployed $16.6M of net new capital in Q1 2025, opening 150 new positions and adding to 30 existing holdings. Its largest new stake was C3.ai: 67,919 shares worth $1.43M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $1.42M trimmed.

  • Semanteon Capital Management's largest Q1 2025 buy was C3.ai: 67,919 shares worth $1.43M.
  • Semanteon Capital Management added most to Booz Allen Hamilton in Q1 2025, an estimated $1.34M increase.
  • Semanteon Capital Management's biggest Q1 2025 reduction was Travere Therapeutics, cutting an estimated $1.42M.
  • Semanteon Capital Management fully exited Delek US in Q1 2025, selling an estimated $1.57M.
  • Semanteon Capital Management's ten largest holdings make up 8.3% of its $184M portfolio in Q1 2025.
  • Semanteon Capital Management opened 150 new positions and closed 142 in Q1 2025.
  • Semanteon Capital Management's portfolio value fell 1.2% quarter-over-quarter to $184M.

Based on Semanteon Capital Management's 13F filing for Q1 2025, filed 13 May 2025.